Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the efficacy and safety and tolerability of
ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.